83 FR 51983 - Importer of Controlled Substances Registration
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 199 (October 15, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 199 (October 15, 2018)
| Page Range | 51983-51983 | |
| FR Document | 2018-22420 |
[Federal Register Volume 83, Number 199 (Monday, October 15, 2018)] [Notices] [Page 51983] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-22420] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Registration ACTION: Notice of registration. ----------------------------------------------------------------------- SUMMARY: Registrant listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances. SUPPLEMENTARY INFORMATION: The company listed below applied to be registered as an importer of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. ------------------------------------------------------------------------ Company FR Docket Published ------------------------------------------------------------------------ Galephar Pharmaceutical 83 FR 37525..... August 1, 2018. Research Inc. ------------------------------------------------------------------------ The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrant to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substance to the above listed company. Dated: September 24, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018-22420 Filed 10-12-18; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 83, No. 199 / Monday, October 15, 2018 / Notices 51983
42696, 42697 (2018). ‘‘Moreover, in the Dated: September 26, 2018. registration by the Drug Enforcement
absence of an application (whether Uttam Dhillon, Administration (DEA) as importers of
timely filed or not), there is nothing to Acting Administrator. various classes of schedule I or II
act upon.’’ Reece, 77 FR at 35055, [FR Doc. 2018–22421 Filed 10–12–18; 8:45 am] controlled substances.
Rampey, 83 FR at 42697. Accordingly, BILLING CODE 4410–09–P
because Registrant has allowed his SUPPLEMENTARY INFORMATION: The
registration to expire and has not filed company listed below applied to be
an application to renew his registration DEPARTMENT OF JUSTICE registered as an importer of various
or for any other registration in Alabama, basic classes of controlled substances.
this case is now moot and will be Drug Enforcement Administration Information on previously published
dismissed. notices is listed in the table below. No
[Docket No. DEA–392]
comments or objections were submitted
Order
Importer of Controlled Substances and no requests for hearing were
Pursuant to 28 CFR 0.100(b) and the submitted for these notices.
Registration
authority thus vested in me by 21 U.S.C.
824(a), I order that the Order to Show ACTION: Notice of registration.
Cause issued to Phillip O. Rawlings, Jr.,
M.D., be, and it hereby is, dismissed. SUMMARY: Registrant listed below have
This Order is effective immediately. applied for and been granted
Company FR Docket Published
Galephar Pharmaceutical Research Inc ................................. 83 FR 37525 .......................................................................... August 1, 2018.
The Drug Enforcement DATES: Registered bulk manufacturers of Administrator of the DEA Diversion
Administration (DEA) has considered the affected basic classes, and Control Division (‘‘Assistant
the factors in 21 U.S.C. 823, 952(a) and applicants therefore, may file written Administrator’’) pursuant to section 7 of
958(a) and determined that the comments on or objections to the 28 CFR part 0, appendix to subpart R.
registration of the listed registrant to issuance of the proposed registration on In accordance with 21 CFR
import the applicable basic classes of or before November 14, 2018. Such 1301.34(a), this is notice that on July 16,
schedule I or II controlled substances is persons may also file a written request 2018, Cambrex High Point Inc., 4180
consistent with the public interest and for a hearing on the application on or Mendenhall Oaks Parkway, High Point,
with United States obligations under before November 14, 2018. North Carolina 27265–8017 applied to
international treaties, conventions, or ADDRESSES: Written comments should be registered as an importer of the
protocols in effect on May 1, 1971. The be sent to: Drug Enforcement following basic classes of controlled
DEA investigated the company’s Administration, Attention: DEA Federal substances:
maintenance of effective controls Register Representative/DPW, 8701
against diversion by inspecting and Controlled Drug
Morrissette Drive, Springfield, Virginia substance code Schedule
testing each company’s physical 22152. All requests for hearing must be
security systems, verifying the sent to: Drug Enforcement Amphetamine ................... 1100 II
company’s compliance with state and Administration, Attn: Administrator, Codeine ............................ 9050 II
local laws, and reviewing the company’s 8701 Morrissette Drive, Springfield, Oxymorphone ................... 9652 II
background and history. Virginia 22152. All requests for hearing Noroxymorphone .............. 9668 II
Therefore, pursuant to 21 U.S.C. should also be sent to: (1) Drug
952(a) and 958(a), and in accordance Enforcement Administration, Attn: The company plans to manufacture
with 21 CFR 1301.34, the DEA has Hearing Clerk/LJ, 8701 Morrissette the above listed controlled substances in
granted a registration as an importer for Drive, Springfield, Virginia 22152; and bulk for distribution to its customers.
schedule I or II controlled substance to (2) Drug Enforcement Administration, Dated: October 1, 2018.
the above listed company. Attn: DEA Federal Register John J. Martin,
Dated: September 24, 2018. Representative/DPW, 8701 Morrissette Assistant Administrator.
Drive, Springfield, Virginia 22152. [FR Doc. 2018–22416 Filed 10–12–18; 8:45 am]
John J. Martin,
Assistant Administrator. SUPPLEMENTARY INFORMATION: The BILLING CODE 4410–09–P
[FR Doc. 2018–22420 Filed 10–12–18; 8:45 am]
Attorney General has delegated his
authority under the Controlled
BILLING CODE 4410–09–P
Substances Act to the Administrator of DEPARTMENT OF JUSTICE
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to Drug Enforcement Administration
DEPARTMENT OF JUSTICE
exercise all necessary functions with [Docket No. DEA–392]
Drug Enforcement Administration respect to the promulgation and
implementation of 21 CFR part 1301,
khammond on DSK30JT082PROD with NOTICES
Bulk Manufacturer of Controlled
incident to the registration of Substances Application: Specgx, LLC
[Docket No. DEA–392]
manufacturers, distributors, dispensers,
Importer of Controlled Substances importers, and exporters of controlled ACTION: Notice of application.
Application: Cambrex High Point, Inc. substances (other than final orders in
connection with suspension, denial, or DATES: Registered bulk manufacturers of
revocation of registration) has been the affected basic classes, and
ACTION: Notice of application.
redelegated to the Assistant applicants therefore, may file written
VerDate Sep<11>2014 21:34 Oct 12, 2018 Jkt 247001 PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 E:\FR\FM\15OCN1.SGM 15OCN1](https://thefederalregister.org/doc/83_FR_52182/page/1.svg)
Document Created: 2018-10-13 10:03:11
Document Modified: 2018-10-13 10:03:11
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of registration. | |
| FR Citation | 83 FR 51983 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR